Which Country Is No. 1 in Biotechnology? Ask almost any life sciences researcher, venture capitalist, or policy analyst which country leads in biotechnology, and you will get the same answer: the United States. It is not a particularly close contest. By most measures that actually matter — the volume and quality of research output, private capital deployment, the number of commercially successful companies, FDA-approved biologics, and Nobel laureates in the life sciences — the U.S. has held a commanding position for the better part of five decades. That said, "dominance" is not the same as "inevitability ." The global biotech landscape has shifted noticeably in the past fifteen years, and anyone who dismisses China's rise or underestimates the quiet productivity of Switzerland and the UK is probably not paying close enough attention. The United States as the Leading Country in Biotechnology The U.S. appears to account for somewhere between 45 and 50 percen...
N ational center for biotechnology information The National Center for Biotechnology Information (NCBI) represents one of the most consequential scientific institutions in modern biomedicine. Established as a division of the United States National Library of Medicine (NLM) — itself a branch of the National Institutes of Health (NIH) — the NCBI functions as the world's preeminent repository for biomedical and genomic data. Located on the sprawling NIH campus in Bethesda, Maryland, the center serves millions of researchers, clinicians, educators, and members of the public every single day. At its core, the National Center for Biotechnology Information exists to advance science and human health by providing open, unrestricted access to biological databases, bioinformatics tools, and computational resources. The NCBI collects, curates, organizes, and disseminates information spanning nucleotide sequences, protein structures, genomic variation, biomedical literature, chemical biology...